Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04244032 · ClinicalTrials.gov registry record · NA
Cognitive Enhancement Through Computerized Training
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04244032: Clinical Trial NA study, sponsored by University of Florida.
NCT04244032 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04244032, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Alcohol use disorder is characterized by widespread neurocognitive impairments, however despite substantial advances in the intervention and treatment of alcohol use disorders, exceptionally few studies have been directed to improving these deficits. This project leverages computerized cognitive training, applied as an adjunct to inpatient treatment, to enhance neurocognitive recovery. This project informs public health and future intervention efforts by interrogating factors critical to intervention efficacy and clarifying relationships between neurocognitive recovery and treatment outcomes, including post-discharge alcohol consumption.
Primary Outcome
Performance on neuropsychological measures indexing working memory capacity. Score range: 0-100 (scores \<40 are poor \[0-16th percentile\]; scores \>60 are good \[84th-100th percentile\]).
Interventions
- BEHAVIORAL Working Memory Training
- BEHAVIORAL Inhibitory Control Training
- BEHAVIORAL Bias Modification Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2024-09-15 |
| Phase | NA |
Why NCT04244032 stopped before completion
NCT04244032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Working Memory Training is the first listed.
NCT04244032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04244032 about?
NCT04244032 is a clinical study titled "Cognitive Enhancement Through Computerized Training". Alcohol use disorder is characterized by widespread neurocognitive impairments, however despite substantial advances in the intervention and treatment of alcohol use disorders, exceptionally few studies have been directed to improving these deficits. This project leverages computerized cognitive tra...
What is the current status of trial NCT04244032?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2021-04-28. Estimated completion is 2024-09-15.
What interventions are being tested in trial NCT04244032?
The interventions under investigation include: Working Memory Training (BEHAVIORAL), Inhibitory Control Training (BEHAVIORAL), Bias Modification Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04244032?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04244032's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI